XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Option Activity

A summary of option activity under the Company’s stock option plan for nine months ended September 30, 2024 is presented below:

 

   Number of
Shares		   Weighted
Average
Exercise
Price		   Total
Intrinsic
Value		   Weighted
Average
Remaining
Contractual
Life (in years)		 
Outstanding as of December 31, 2023   1,200,000   $2.12   $8,700    2.4 
Employee options granted   120,000    1.52    -    4.6 
Employee options expired   (17,500)   10.30    -    - 
Outstanding as of September 30, 2024   1,302,500   $1.96   $1,650    1.9 
Options vested and exercisable as of September 30, 2024   1,127,500   $2.03   $-    1.5 
Summary of Restricted Stock

A summary of the Company’s restricted stock units granted under the 2021 Plan during the nine months ended September 30, 2024 are as follows:

 

   Number of
Restricted
Stock Units		   Weighted
Average Grant
Date Fair Value		 
Nonvested at December 31, 2023   1,606,373   $     3.25 
Granted   300,000    1.71 
Forfeited   (100,000)   1.63 
Nonvested at September 30, 2024   1,806,373   $3.09 
Schedule of Stock-based Compensation Expense

Stock-based compensation expense is recorded as a part of selling, general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 was as follows:

 

   2024   2023   2024   2023 
   For the Three Months Ended
September 30,		   For the Nine Months Ended
September 30,		 
   2024   2023   2024   2023 
Employee stock option awards  $34,601   $441   $66,594   $(4,871)
Employee restricted stock unit awards   244,409    230,118    725,307    726,409 
Employee share-based salary payments   75,468    -    75,468    - 
Non-employee restricted stock awards   66,929    21,536    127,509    45,777 
Stock-based compensation  $421,407   $252,095   $994,878   $767,315 
2021 Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value 

   Nine Months Ended
September 30,		 
   2024   2023 
Exercise price  $1.55   $0.63 
Term (years)   5.00    5.00 
Expected stock price volatility   144.57%   152.84%
Risk-free rate of interest   4.31%   3.99%